<DOC>
	<DOC>NCT00316641</DOC>
	<brief_summary>The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients</brief_summary>
	<brief_title>The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Patient aged 2065 years;either sex Patient diagnosed with hyperlipidemia(fasting levels of TC&gt;=200mg/dL),or TG&gt;=200mg/dL but &lt;400mg/dL,or LDLC&gt;=130mg/dL) Patient who has signed the informed consent form Patient with pregnancy (or child bearing potential),or in lactation Patient with any lipid regulating agents within 4 weeks prior to study period Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, βblockers, cyclosporins, itraconazole erythromycin,and danazol) Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis. Patient with liver dysfunction (SGOT or SGPT&gt;2x ULN) Patient with renal insufficiency (serum creatinine&gt;1.3mg/dL) Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>